Audrieanna Raciti
Payments from drug & device makers
Across 60 payments — averaging $53.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teva Pharmaceuticals USA, Inc.$540
- AstraZeneca$262
- AbbVie$250
- Braeburn Inc.$244
- Otsuka America Pharmaceutical, Inc.$185
- Neurocrine Biosciences, Inc.$174
- plus $2K from 19 others
What the payments were for
- Food & beverage$3,189100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 20 | $540 |
| AstraZeneca(2 entities) | 4 | $262 |
| AbbVie | 2 | $250 |
| Braeburn Inc. | 3 | $244 |
| Otsuka America Pharmaceutical, Inc. | 3 | $185 |
| Neurocrine Biosciences, Inc. | 4 | $174 |
| Amarin Pharma, Inc. | 2 | $164 |
| Boston Scientific | 2 | $151 |
| Silk Road Medical, Inc. | 1 | $125 |
| Agios Pharmaceuticals, Inc. | 1 | $125 |
| Alkermes, Inc. | 1 | $120 |
| GSK | 1 | $116 |
| Axsome Therapeutics, Inc. | 1 | $105 |
| Abiomed | 1 | $92 |
| Amgen | 1 | $92 |
| Idorsia Pharmaceuticals US Inc | 1 | $79 |
| Eisai Inc. | 1 | $76 |
| Grifols USA, LLC | 1 | $61 |
| Lilly USA, LLC | 3 | $46 |
| Avanir Pharmaceuticals, Inc. | 2 | $45 |
| Mylan Specialty L.p. | 1 | $43 |
| Sun Pharmaceutical Industries Inc. | 1 | $30 |
| Shield Therapeutics Inc | 1 | $24 |
| Johnson & Johnson | 1 | $21 |
| Merck | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,189 in reported general payments places this provider in the 85th percentile of 8,883 family providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Invega SustennaPaliperidone Palmitate | 24 | $86,292 |
| EliquisApixaban | 235 | $68,617 |
| TrulicityDulaglutide | 74 | $61,482 |
| IngrezzaValbenazine Tosylate | 14 | $50,736 |
| XifaxanRifaximin | 23 | $38,970 |
| XareltoRivaroxaban | 141 | $37,936 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 43 | $30,047 |
| JardianceEmpagliflozin | 79 | $24,777 |
| Risperdal ConstaRisperidone Microspheres | 19 | $24,744 |
| Risperidone ErRisperidone Microspheres | 21 | $22,160 |
| OzempicSemaglutide | 21 | $21,567 |
| LinzessLinaclotide | 24 | $13,811 |
| VraylarCariprazine Hcl | 21 | $12,844 |
| EntrestoSacubitril/Valsartan | 33 | $9,102 |
| NamzaricMemantine Hcl/Donepezil Hcl | 28 | $8,250 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonInvega Sustenna, Xarelto, Risperdal Consta | $21 | $148,971184 claims |
| Lilly USA, LLCTrulicity, Olanzapine | $46 | $66,124211 claims |
| Neurocrine Biosciences, Inc.Ingrezza | $174 | $50,73614 claims |
| AbbVieLinzess, Vraylar, Namzaric | $250 | $34,90573 claims |
| GSKTrelegy Ellipta | $116 | $30,04743 claims |
| AstraZenecaLokelma, Farxiga | $262 | $12,38228 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 8,883 family providers in New York.
Other family in Utica
- Jenna PawloskiUtica$62K
- Nicolette HaleyUtica$19K
- Christina NalboneNew York$197K
- Casey GrilloNew York$191K
- Suzanne WilsonIthaca$179K
- Jonathan LesuerSyracuse$172K
- Sheri HillNorth Syracuse$165K
- Cathrine CurtinBronxville$155K
- Mary Sullivan-WhalenNew York$137K
- Sarah AljahmiRockville Centre$87K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.